Cargando…
Gut Immunobiosis and Biomodulators
The human gastrointestinal (GI) tract hosts complex and dynamic populations of microorganisms (gut microbiota) in advantageous symbiosis with the host organism through sophisticated molecular cross-talk. The balance and diversification within microbial communities (eubiosis) are crucial for the immu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180914/ https://www.ncbi.nlm.nih.gov/pubmed/37432248 http://dx.doi.org/10.3390/nu15092114 |
_version_ | 1785041448557608960 |
---|---|
author | Miniello, Vito Leonardo Miniello, Andrea Ficele, Laura Skublewska-D’Elia, Aleksandra Dargenio, Vanessa Nadia Cristofori, Fernanda Francavilla, Ruggiero |
author_facet | Miniello, Vito Leonardo Miniello, Andrea Ficele, Laura Skublewska-D’Elia, Aleksandra Dargenio, Vanessa Nadia Cristofori, Fernanda Francavilla, Ruggiero |
author_sort | Miniello, Vito Leonardo |
collection | PubMed |
description | The human gastrointestinal (GI) tract hosts complex and dynamic populations of microorganisms (gut microbiota) in advantageous symbiosis with the host organism through sophisticated molecular cross-talk. The balance and diversification within microbial communities (eubiosis) are crucial for the immune and metabolic homeostasis of the host, as well as for inhibiting pathogen penetration. In contrast, compositional dysregulation of the microbiota (dysbiosis) is blamed for the determinism of numerous diseases. Although further advances in the so-called ‘omics’ disciplines are needed, dietary manipulation of the gut microbial ecosystem through biomodulators (prebiotics, probiotics, symbionts, and postbiotics) represents an intriguing target to stabilize and/or restore eubiosis. Recently, new approaches have been developed for the production of infant formulas supplemented with prebiotics (human milk oligosaccharides [HMOs], galacto-oligosaccharides [GOS], fructo-oligosaccharides [FOS]), probiotics, and postbiotics to obtain formulas that are nutritionally and biologically equivalent to human milk (closer to the reference). |
format | Online Article Text |
id | pubmed-10180914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101809142023-05-13 Gut Immunobiosis and Biomodulators Miniello, Vito Leonardo Miniello, Andrea Ficele, Laura Skublewska-D’Elia, Aleksandra Dargenio, Vanessa Nadia Cristofori, Fernanda Francavilla, Ruggiero Nutrients Review The human gastrointestinal (GI) tract hosts complex and dynamic populations of microorganisms (gut microbiota) in advantageous symbiosis with the host organism through sophisticated molecular cross-talk. The balance and diversification within microbial communities (eubiosis) are crucial for the immune and metabolic homeostasis of the host, as well as for inhibiting pathogen penetration. In contrast, compositional dysregulation of the microbiota (dysbiosis) is blamed for the determinism of numerous diseases. Although further advances in the so-called ‘omics’ disciplines are needed, dietary manipulation of the gut microbial ecosystem through biomodulators (prebiotics, probiotics, symbionts, and postbiotics) represents an intriguing target to stabilize and/or restore eubiosis. Recently, new approaches have been developed for the production of infant formulas supplemented with prebiotics (human milk oligosaccharides [HMOs], galacto-oligosaccharides [GOS], fructo-oligosaccharides [FOS]), probiotics, and postbiotics to obtain formulas that are nutritionally and biologically equivalent to human milk (closer to the reference). MDPI 2023-04-28 /pmc/articles/PMC10180914/ /pubmed/37432248 http://dx.doi.org/10.3390/nu15092114 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Miniello, Vito Leonardo Miniello, Andrea Ficele, Laura Skublewska-D’Elia, Aleksandra Dargenio, Vanessa Nadia Cristofori, Fernanda Francavilla, Ruggiero Gut Immunobiosis and Biomodulators |
title | Gut Immunobiosis and Biomodulators |
title_full | Gut Immunobiosis and Biomodulators |
title_fullStr | Gut Immunobiosis and Biomodulators |
title_full_unstemmed | Gut Immunobiosis and Biomodulators |
title_short | Gut Immunobiosis and Biomodulators |
title_sort | gut immunobiosis and biomodulators |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180914/ https://www.ncbi.nlm.nih.gov/pubmed/37432248 http://dx.doi.org/10.3390/nu15092114 |
work_keys_str_mv | AT miniellovitoleonardo gutimmunobiosisandbiomodulators AT minielloandrea gutimmunobiosisandbiomodulators AT ficelelaura gutimmunobiosisandbiomodulators AT skublewskadeliaaleksandra gutimmunobiosisandbiomodulators AT dargeniovanessanadia gutimmunobiosisandbiomodulators AT cristoforifernanda gutimmunobiosisandbiomodulators AT francavillaruggiero gutimmunobiosisandbiomodulators |